PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo - Wikidata - wikimedia - TriplyDB

PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo

PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo

http://www.wikidata.org/entity/Q30493965

about

The Two-Faced Potato Virus X: From Plant Pathogen to Smart Nanoparticle Fluorescent Tobacco mosaic virus-Derived Bio-Nanoparticles for Intravital Two-Photon Imaging.Engineering of Brome mosaic virus for biomedical applications Size Dependent Cellular Uptake of Rod-like Bionanoparticles with Different Aspect Ratios.Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells.Intravital imaging of embryonic and tumor neovasculature using viral nanoparticles.Increased tumor homing and tissue penetration of the filamentous plant viral nanoparticle Potato virus X.Polyethylene glycol-grafted polyethylenimine used to enhance adenovirus gene delivery.Supramolecular protein cage composite MR contrast agents with extremely efficient relaxivity properties.Viral nanoparticles as platforms for next-generation therapeutics and imaging devices Biodistribution and clearance of a filamentous plant virus in healthy and tumor-bearing mice.Potato virus X as a novel platform for potential biomedical applications.Synthetic virology: engineering viruses for gene delivery Applications of viral nanoparticles in medicine.Complement activation and cell uptake responses toward polymer-functionalized protein nanocapsules.Molecular targeted viral nanoparticles as tools for imaging cancer Design of nanovectors for therapy and imaging of cardiovascular diseases Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells Coarse-grained model for PEGylated lipids: effect of PEGylation on the size and shape of self-assembled structures Shape matters: the diffusion rates of TMV rods and CPMV icosahedrons in a spheroid model of extracellular matrix are distinct Molecular dynamics study of the structure and interparticle interactions of polyethylene glycol-conjugated PAMAM dendrimers.Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice Targeting cancer with 'smart bombs': equipping plant virus nanoparticles for a 'seek and destroy' mission.Controlling forces and pathways in self-assembly using viruses and DNA.Caged protein nanoparticles for drug delivery.Functionalization of protein-based nanocages for drug delivery applications.Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors.Viral chemistry: the chemical functionalization of viral architectures to create new technology.Evaluation of nanoparticle uptake in tumors in real time using intravital imaging.Hydrazone ligation strategy to assemble multifunctional viral nanoparticles for cell imaging and tumor targeting.Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.Synthetic plant virology for nanobiotechnology and nanomedicine Guiding plant virus particles to integrin-displaying cells Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature.Dual Functionalized Bacteriophage Qβ as a Photocaged Drug Carrier.Differential uptake of chemically modified cowpea mosaic virus nanoparticles in macrophage subpopulations present in inflammatory and tumor microenvironments.Stabilization of virus-like particles with poly(2-oxazoline)s.Display of DNA on Nanoparticles for Targeting Antigen Presenting Cells.Two Domains of Vimentin Are Expressed on the Surface of Lymph Node, Bone and Brain Metastatic Prostate Cancer Lines along with the Putative Stem Cell Marker Proteins CD44 and CD133.

P2860

Q26774624-BDDFFD17-9795-48FD-87E2-D5A7C9915922 Q27307604-27EB1892-B809-4924-9CA4-00F6399541D0 Q28818683-680973DC-C0F2-4A72-8B28-3E01F35FDF09 Q30385575-C967AAF3-A7A3-47FF-AB2E-E972C17ED5E4 Q30500177-17FEE2A4-B148-4654-93AD-496D8632CB11 Q30503845-980C23AE-028E-4F47-BBE8-442542F8A1E8 Q30527772-6E8AE923-09DD-4D41-B873-0FBAAD569B69 Q31118305-135A4873-8FFF-4975-B34E-177956FF7823 Q33514896-656CF417-8871-453B-9A78-EE0808652467 Q34168677-0F5C3A9E-0000-4B65-A23C-AB1BEB2452DA Q34213499-B5B0432B-07B1-4C7B-B6C2-DF75D7302E91 Q34219033-90ADC6B7-23B6-4B1E-B7CF-B0992A149E5A Q34487264-452CE98C-795D-4269-BAF5-A42DC9446D89 Q35501007-F1EE5C07-3D34-4166-A24D-CB6307B308EC Q35878143-0CAB1ECE-5FF6-4BA4-88CA-2A8617D3A49A Q35988369-8EB0E1DE-0722-4B9E-86EE-A40E1A8843BC Q36119295-5CBDC7C6-F187-4DB9-97E3-0B7929E9744C Q36218232-0EA1ECDD-A740-4F89-AEA6-0256F98B7590 Q36290628-A47E2A71-0F8D-4E1B-BBC1-51CBF35477D1 Q37298480-87E650E8-DDCA-4E45-BD97-C07C498AE369 Q37409520-858C41AB-E135-4E53-95AB-252B17CADE03 Q37531135-DFBFDDD3-8624-403A-A43F-EF7B82CDD09F Q37538780-48B7C4FF-7E0D-47FF-A308-ECEBB254F482 Q37850774-F64BB308-57E7-463E-A3BF-39F3ABE58A2F Q38212056-594A3C3E-3AF1-4463-8CFA-5F40783C7081 Q38214775-D1BFC774-5EC7-4FD0-AA9B-1A85C5D26861 Q38269032-A80FC188-7BDA-4C5C-B6DA-47C379464850 Q38668484-D982E8A5-50C3-4273-BDC5-511F6EC32973 Q38758393-F1EE28B6-4281-4C7D-9F8C-C26C6474771B Q38784255-32ED8A83-5DD6-4FAE-861B-51932AF889ED Q39068831-04D93673-60D2-4CB0-9BA4-FA7266D31069 Q39076542-D5756D40-09BE-450F-A08E-1CBA3F7516CD Q39081725-C951FBD3-CF0D-42BB-9DC8-795452F408C6 Q39348354-343ACE66-8CE6-4C2E-9176-84C2CDD962F1 Q40086225-0EB239D5-FBD3-4414-8CF8-351253D60560 Q40678773-D87ABA30-180D-4CC5-BEDD-A2BDDA91C909 Q41527294-EF583E58-4638-4843-B448-356889A31B89 Q41995319-6B8C74CA-7BA0-4E8B-B9CC-5895C2EE7D56 Q42099934-3E5A0001-FEF8-4F79-A858-C87F1CDFBD25 Q42579648-3916C942-C459-4DFD-9659-4746671A70C6

P2860

PEGylated viral nanoparticles for biomedicine: the impact of PEG chain length on VNP cell interactions in vitro and ex vivo

http://www.wikidata.org/entity/Q30493965

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@ast

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@en

type

label

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@ast

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@en

prefLabel

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@ast

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@en

P1433

Q30493965-102C8AAB-757E-412A-B6C2-9F19BC082D62

P1476

Q30493965-195D76F1-D80B-4807-91B5-8D3BDA6E64C0

P2093

Q30493965-673C0B01-7228-4511-8506-9C92666E5E32

P2860

Q30493965-0879D1DF-0CD3-4A94-A122-A9E8C55EC9E0

Q30493965-088DF776-2B7D-47EC-81ED-899E02A7DC90

Q30493965-09630A32-1E1C-410A-B03B-1C3C8FAB0D4C

Q30493965-0E813FEF-D30E-40DD-839A-94BF2AC4F9DC

Q30493965-12375A55-9EFE-45E4-80FF-1A16028B4423

Q30493965-128C109D-2348-42DE-A97E-E1C884AE17E2

Q30493965-17F05FA7-387F-4226-9472-8E49E099DC03

Q30493965-31F790D4-195D-4D06-9A3A-D91CF7E36FE9

Q30493965-3386095A-E12F-458F-AFBD-BF4AE4121165

Q30493965-3A139EE1-9A94-4E5D-8413-071F4B2091DA

P304

Q30493965-89D2EA42-4641-498E-84F3-2E2CE47D33E0

P31

Q30493965-3301E0C7-663E-4497-B4AF-EA3A5666EC2F

P356

Q30493965-6E4073A4-DFD1-4998-9520-A7794A2E452F

P433

Q30493965-1DF77C9C-9774-4251-89C9-3BDA982E29CF

P478

Q30493965-588ADCAB-6251-45FD-B1A2-E9BFDBEEA17D

P50

Q30493965-16F80D31-B8E7-4B50-BBE2-1750D3D789B3

P577

Q30493965-436C5F25-720C-4B99-8A02-51CA553D4575

P5875

Q30493965-F0A12483-E65F-418B-B252-911DFD9DE76A

P698

Q30493965-D1688CCF-29C1-4E3E-B599-7919BC1BD6FA

P921

Q30493965-84B71904-EB20-49A4-B739-1A7CA0B3030A

P932

Q30493965-38B623B1-F904-4E7D-A7D6-D993035E261D

P356

P1433

Biomacromolecules

P1476

PEGylated viral nanoparticles ...... eractions in vitro and ex vivo

@en

P2093

Nicole F Steinmetz

http://www.w3.org/2001/XMLSchema#string

P2860

Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism.

The refined crystal structure of cowpea mosaic virus at 2.8 A resolution

Surface modification of tobacco mosaic virus with "click" chemistry.

Chemistry for peptide and protein PEGylation.

Effect of pegylation on pharmaceuticals.

Interaction between a 54-kilodalton mammalian cell surface protein and cowpea mosaic virus.

Solution structure of poly(ethylene) glycol-conjugated hemoglobin revealed by small-angle X-ray scattering: implications for a new oxygen therapeutic

Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells

Viral nanoparticles as tools for intravital vascular imaging.

PEGylation as a tool for the biomedical engineering of surface modified microparticles.

P304

784-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/BM8012742

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P50

Marianne Manchester

P577

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24196058

http://www.w3.org/2001/XMLSchema#string

P698

19281149

http://www.w3.org/2001/XMLSchema#string

P921

P932

2849976

http://www.w3.org/2001/XMLSchema#string